Company news
Hikma Pharmaceuticals PLC news in 2017
Hikma Pharmaceuticals PLC's news releases, calls and decks from 2017, newest first.
Hikma reaches licensing agreement with Celltrion
December 19, 2017
Hikma- Dihydroergotamine Mesylate Injection, USP
December 13, 2017
Hikma Ventures- $20.5m Series C round for Prognos
November 30, 2017
Announcement
November 28, 2017
Hikma Ventures invests in Biolinq
November 27, 2017
Hikma Acquires Products from Boehringer Ingelheim
November 14, 2017
Hikma launches Flucytosine Capsules USP in US
November 3, 2017
Hikma launches Pantoprazole Sodium for Injection
October 30, 2017
Hikma announces licensing agreement with Takeda
August 17, 2017
Leadership and Structural Changes to US Business
June 26, 2017
Hikma update on ANDA for generic Advair Diskus
May 11, 2017
Change of Registered Address
May 8, 2017
Change of Registered Office
May 3, 2017
Hikma enters into settlement agreement with Jazz
April 6, 2017
Hikma launches Desvenlafaxine Succinate Tablets
March 10, 2017
Licensing agreement with Orion for Easyhaler®
February 13, 2017
Hikma receives approval for Sodium Oxybate
January 18, 2017
Decks in 2017
- H1 2017 Earnings Presentation
Earnings · 33 slides · Aug 17, 2017
- FY2016 Earnings Presentation
Earnings · 40 slides · Mar 15, 2017